MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 01-14-2026
Biomerica ROA Ratio 2011-2026 | BMRA
Annual ROA Ratio Biomerica
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -83.65 | -64.6 | -49.4 | -39.84 | -63.0 | -13.55 | -45.62 | -28.07 | -18.11 | -26.19 | -5.41 | -3.33 | 8.4 | 9.84 | 3.18 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 9.84 | -83.65 | -27.96 |
Quarterly ROA Ratio Biomerica
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -53.38 | -44.57 | -45.55 | -64.1 | -66.87 | -66.55 | -39.85 | -59.94 | -61.5 | -65.17 | -55.26 | -87.77 | -68.27 | -59.45 | -54.1 | -44.16 | -61.54 | -65.81 | -64.32 | -50.36 | -41.94 | -36.96 | -32.59 | -33.23 | -33.33 | -35.22 | -36.96 | -36.85 | -35.84 | -32.61 | -27.56 | -23.78 | -19.26 | -17.33 | -14.1 | -12.29 | -9.13 | -6.62 | -6.83 | -4.37 | -4.59 | -7.48 | -9.91 | -12.5 | -14.71 | -14.87 | -13.95 | -14.07 | -13.31 | -5.22 | 2.36 | 10.42 | 18.28 | 18.21 | 15.7 | 15.39 | 12.53 | 2.37 | 3.94 | 2.38 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 18.28 | -87.77 | -28.07 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
11.3 | $ 110.31 | -2.79 % | $ 33.5 B |  USA |
 |
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Waters Corporation
WAT
|
12.66 | $ 289.46 | -3.69 % | $ 17.2 B | USA |
 |
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
-3.55 | - | - | $ 19.8 B | USA |
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Sotera Health Company
SHC
|
2.39 | $ 13.12 | -3.14 % | $ 3.73 B | USA |
 |
Check-Cap Ltd.
CHEK
|
-6670.82 | - | - | $ 9.42 M |  Israel |
 |
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M |  Britain |
 |
BioNano Genomics
BNGO
|
-35.87 | $ 1.15 | -0.43 % | $ 6.26 M | USA |
 |
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
-156.39 | - | -6.19 % | $ 10.5 M | USA |
 |
DexCom
DXCM
|
13.19 | $ 62.39 | -5.61 % | $ 24.3 B | USA |
 |
Accelerate Diagnostics
AXDX
|
-22.47 | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-34.28 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | China |
 |
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | USA |
 |
Castle Biosciences
CSTL
|
3.43 | $ 23.59 | -4.49 % | $ 655 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | USA |
 |
Charles River Laboratories International
CRL
|
-2.02 | $ 158.5 | -4.02 % | $ 7.86 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
6.11 | $ 195.05 | -1.56 % | $ 21.7 B | USA |
 |
Organovo Holdings
ONVO
|
-16.98 | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
121.6 | - | -16.95 % | $ 1.54 M | USA |
 |
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | USA |
 |
PerkinElmer
PKI
|
1.98 | - | -0.91 % | $ 14.7 B | USA |
 |
Invitae Corporation
NVTA
|
-5.11 | - | - | $ 21.2 M | USA |
 |
Interpace Biosciences
IDXG
|
45.31 | $ 1.68 | -2.89 % | $ 7.37 M | USA |
 |
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K | Israel |
 |
QIAGEN N.V.
QGEN
|
1.47 | - | - | $ 10.6 B |  Niderland |
 |
Neogen Corporation
NEOG
|
-31.71 | $ 8.71 | -4.86 % | $ 1.89 B | USA |
 |
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
4.77 | $ 264.08 | -1.6 % | $ 22 B | USA |
 |
Psychemedics Corporation
PMD
|
-33.7 | - | -1.84 % | $ 15.3 M | USA |
 |
Precipio
PRPO
|
-32.34 | $ 25.69 | -5.55 % | $ 33.3 M | USA |
 |
CareDx, Inc
CDNA
|
-5.17 | $ 16.68 | -4.55 % | $ 889 M | USA |
 |
Quotient Limited
QTNT
|
-50.51 | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Syneos Health
SYNH
|
2.85 | - | - | $ 4.46 B | USA |
 |
Renalytix AI plc
RNLX
|
-419.67 | - | 5.66 % | $ 22.7 M | Britain |
 |
VolitionRx Limited
VNRX
|
-289.99 | $ 0.19 | -0.08 % | $ 18.3 M |  Singapore |
|
Biodesix
BDSX
|
-44.15 | $ 14.29 | -2.16 % | $ 1.85 B | USA |
 |
Celcuity
CELC
|
-37.95 | $ 108.63 | -5.38 % | $ 5.08 B | USA |
 |
Burning Rock Biotech Limited
BNR
|
-34.96 | $ 16.61 | -10.22 % | $ 179 M | China |
 |
Bioventus
BVS
|
3.33 | $ 8.93 | -3.62 % | $ 595 M | USA |
 |
Brainsway Ltd.
BWAY
|
-8.53 | $ 12.8 | -5.11 % | $ 99.4 M | Israel |
 |
Co-Diagnostics
CODX
|
-37.07 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Meridian Bioscience
VIVO
|
9.17 | - | - | $ 1.49 B | USA |